Summary
Although sodium benzoate therapy is beneficial in patients with inborn error of urea cycle, it has been suggested that an accumulation of benzoyl-CoA would inhibit ureagenesis. In this study, we examined several aspects of ureagenesis after the single oral dosing of sodium benzoate in six healthy subjects who participated in the study previously reported and in two patients with citrullinaemia.
Urea nitrogen appearance (UNA) did not change after the doses of 40, 80 and 160 mg·kg−1 of sodium benzoate in the 6 healthy subjects. Sum of UNA and urinary hippurate nitrogen (UHN) increased with increasing the dose. In the 2 patients with late-onset citrullinaemia who benefit from a partially functional urea cycle, no apparent inhibitory effects on the UNA were observed after the administration of 80 mg/kg of sodium benzoate.
The precursors of urea (ammonia, glutamate, glutamine and α-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Killenberg PG, Webster LT (1980) Conjugation by peptide bond formation. In: Jakoby B (ed) Enzymatic basis of detoxication, vol 2. Academic Press, New York, pp 414–467
Londersborough JC, Webster LT (1974) Fatty acyl-CoA syntheses. In: Boyer PO (ed) The enzymes. Academic Press, New York, pp 469–488
Brusilow SW, Valle DL, Batshaw ML (1979) New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet II: 452–454
Batshaw ML, Thomas GH, Brusilow SW (1981) New approaches to the diagnosis and treatment of inborn errors of urea synthesis. Pediatrics 68: 290–297
Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, Cann HM, Kerr D, Mamunes P, Matalon R, Myerberg D, Shafer IA (1982) Treatment of inborn errors of urea synthesis. N Engl J Med 306: 1387–1392
Mitch W, Brusilow S (1982) Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure. J Pharmacol Exp Ther 222: 572–575
O'Connor JE, Ribelles M, Grisolia S (1982) Potentiation of hyperammonemia by sodium benzoate in animals: a note of caution. Eur J Pediatr 138: 186–187
Maswoswe SM, Cyr DM, Griffith AD, Tremblay GC (1986) The effect of sodium benzoate on ammonia toxicity in rats. Biochem Biophys Res Commun 138: 369–373
Cyr DM, Maswoswe SM, Tremblay GC (1987) Inhibition of the urea cycle and de novo pyrimidine biosynthesis by sodium benzoate. J Inher Metab Dis 10 [Suppl 2]: 308–310
Quick AJ (1931) The conjugation of benzoic acid in man. J Biol Chem 92: 65–85
Batshaw ML, Brusilow SW (1981) Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies. J Inher Metab Dis 4: 231
Brusilow SW, Danney M, Waber LJ et al (1984) Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310: 1630–1634
Letarte J, Qureshi IA, Ouellet R, Godard M (1985) Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency. J Pediatr 106: 794–797
Takeda E, Kuroda Y, Toshima K, Watanabe T, Naito E, Miyano M (1983) Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency. Clin Pediatr 22: 206–208
Kubota K, Ishizaki T (1991) Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans. Eur J Clin Pharmacol 41: 363–368
Walser M (1983) Urea cycle disorders and other hereditary hyperammonemic syndromes. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 402–438
Saheki T, Kobayashi K, Miura T, et al (1986) Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J Clin Biochem Nutr 1: 129–142
Kurahashi K, Ishihara A, Uehara H (1972) Determination of ammonia in blood plasma by an ion exchange method. Clin Chim Acta 42: 141–146
Sampson EJ, Baird MA (1979) Chemical inhibition used in a kinetic urease/glutamate dehydrogenase method for urea in serum. Clin Chem 25: 1721–1729
Goodwin JF (1970) Spectrophotometric quantitation of plasma and urinary amino nitrogen with fluorodinitrobenzene. Stand Meth Clin Chem 6: 89–98
Walser M, Coulter AW, Dighe S, Crantz FR (1973) The effect of keto-analogues of essential amino acids in severe chronic uremia. J Clin Invest 52: 678–690
Bursilow S, Tinker J, Batshaw ML (1980) Amino acid acylation: A mechanism of nitrogen excretion in inborn errors of urea synthesis. Science 207: 659–661
Oyanagi K, Kuniya Y, Tsuchiyama A, et al (1987) Nonlinear elimination of benzoate in patients with congenital hyperammonemia. J Pediatr 110: 634–636
Gatley SJ, Sherratt HS (1977) The synthesis of hippurate from benzoate and glycine by rat liver mitochondria: submitochondrial localization and kinetics. Biochem J 166: 39–47
Coude FX, Rabier D, Cathelineau L, Grimber G, Parvy P, Kamoun PP (1981) A mechanism for valproate-induced hyperammonemia. Pediatr Res 15: 974–975
Honeycutt D, Callaham K, Rutledge L, Evans B (1992) Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Neurology 42: 666–668
Hjelm M, Silva LVK, Seakin JWT, Oberholzer VG (1986) Evidence of inherited urea cycle defect in a case of fatal valproate toxicity. Br Med J 292: 23–24
Tokatli A, Coskun T, Cataltepe S, Özalp I (1991) Valproate- induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency. J Inher Metab Dis 14: 836–837
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kubota, K., Ishizaki, T. Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia. Eur J Clin Pharmacol 45, 465–468 (1993). https://doi.org/10.1007/BF00315519
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315519